Sanprobi

What Sanprobi does

Sanprobi is a Polish manufacturer of premium probiotic, postbiotic, and prebiotic dietary supplements, founded in 2008 and headquartered in Szczecin. The company operates as a limited partnership (Sp. z o.o. Sp. K.) with 11–50 employees and sells a portfolio of 16 stock-keeping units exclusively through Polish pharmacies, supplemented by a dedicated e-commerce site (akkermansia.pl) for its postbiotic line. Its product range spans multi-strain core probiotic formulas, a two-product Mycobiotic Duo range (Pro-Psyche and Pro-Immune), a premium Akkermansia muciniphila MucT postbiotic line that holds EU Novel Food approval, and a prebiotic fibre product.

The company runs an in-house research and development function supported by a bioinformatics team that uses next-generation sequencing, flow cytometry, and mass spectrometry for strain characterisation and product validation. Manufacturing is performed in Sanprobi's own facility, which has a stated capacity of 84,000 capsules per hour, is GMP- and HACCP-certified, and was partly funded by an EU innovation grant. Several products carry positive opinions from the Children's Memorial Health Institute in Warsaw, and the business received Forbes Diamenty recognition in 2020 as a high-growth Polish company.

Commercially, Sanprobi operates a premium consumer-health model: products are priced above commodity supplement benchmarks and are sold only through licensed pharmacies, supported by a medical representative sales force covering all Polish voivodeships and a recently opened Warsaw branch office. Recent product development activity has been concentrated in postbiotics and condition-specific formulations (IBS, immune support, gut barrier), indicating an R&D-led product strategy rather than a volume-led commodity play.

Name

Sanprobi

Legal name

SANPROBI Sp. z o.o. Sp. K.

Website

https://sanprobi.pl

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Sanprobi is a Polish manufacturer of premium probiotic, postbiotic, and prebiotic dietary supplements, founded in 2008, selling 16 products through pharmacies in Poland and via dedicated e-commerce for its EU-approved Akkermansia line.

Ownership category

akta.pro rank

Product category

Probiotic and postbiotic dietary supplements

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

akta.pro secondary industries

Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Probiotic, Prebiotic & Gut-Health Foods Manufacturing (Fermented Functional Foods, Synbiotics) (AFAKAJAH)

Keywords

• Probiotic supplements
• Postbiotic supplements
• Gut health products
• Microbiome research
• Dietary supplements

Headquarters

HQ city

Szczecin

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Probiotic supplement sales: Sanprobi generates revenue through the sale of probiotic and postbiotic dietary supplements. Products are distributed exclusively through pharmacies (not drugstores or supermarkets) and online pharmacy aggregators. Premium products (SANPROBI Premium line with Akkermansia) are sold through dedicated website akkermansia.pl. The company also sells directly to consumers online.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Sanprobi develops, manufactures and sells branded probiotic, postbiotic and prebiotic dietary supplements distributed exclusively through pharmacies (physical and online) in Poland. Its portfolio covers single-strain and multi-strain probiotics (e.g., SANPROBI IBS, 4 Enteric, Active & Sport, Immuno + D3), mycobiotic combinations with medicinal mushrooms (Pro-Immune, Pro-Psyche), the SANPROBI Premium line with pasteurized Akkermansia muciniphila MucT, and Bimuno galacto-oligosaccharide prebiotic fiber supplements (FIBRE GOS and GOS FORTE). Production and R&D are conducted in-house at a pharmaceutical-grade GMP facility and laboratory in Szczecin.

Product overview

Sanprobi is a Polish probiotic and postbiotic supplement manufacturer founded in 2008, operating as a small-to-medium enterprise with in-house research laboratory and the most advanced probiotic packaging plant in Europe. The product portfolio consists of 16 distinct dietary supplements organized into three tiers: (1) Core probiotic products including SANPROBI IBS (with L. plantarum 299v strain in capsule and liquid drop forms), SANPROBI Stress, SANPROBI Super Formula, SANPROBI Barrier/Barrier Forte, SANPROBI Active & Sport, SANPROBI 4 Enteric (enteric-coated multi-strain), and SANPROBI Immuno + D3 (multi-strain with vitamin D3); (2) Mycobiotic Duo products combining probiotics with medicinal mushrooms (SANPROBI Pro-Immune with shiitake and SANPROBI Pro-Psyche with lion's mane); and (3) Premium postbiotic line marketed as 'The Akkermansia Company' featuring pasteurized Akkermansia muciniphila MucT bacteria in SANPROBI Premium, SANPROBI Premium Beauty (with skin-supporting ingredients), and SANPROBI Premium Slim (with metabolic support). Add-on prebiotic fiber supplements (SANPROBI FIBRE GOS and GOS Forte) use Bimuno galacto-oligosaccharides to support probiotic efficacy. All products are pharmaceutical-grade supplements sold exclusively through pharmacies, manufactured under GMP-equivalent standards with pharmaceutical cleanroom parameters (20°C, <40% humidity, HEPA 13 filtration). The company holds positive opinions from the Children's Memorial Health Institute for multiple products.

Differentiator

Problem solved

Functional benefit

Brands

• SANPROBI® PREMIUM – The Akkermansia Company™: Premium line of postbiotic products containing pasteurised Akkermansia muciniphila bacteria for gut microbiota supplementation.
• SANPROBI® PREMIUM Beauty
• SANPROBI® PREMIUM Slim

Quantifiable outcome

• Bifidobacteria numbers in intestines increase within 7 days following first administration of galacto-oligosaccharides (GOS) in SANPROBI Fibre products
• +2 more outcomes

Segments7 records

Ideal customer profiles6 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators6 records

Broad incumbents

• Novonesis (formerly Chr. Hansen): Global bioscience company and leading probiotic strain supplier powering many branded probiotic products; broader portfolio includes enzymes and cultures. Relevant incumbent in the same ingredient category Sanprobi accesses.
• Danone (Actimel / Activia): Global food major with probiotic dairy brands Actimel and Activia across European mass retail; competing for the same gut-health consumer wallet as Sanprobi.
• Yakult Honsha: Japanese pioneer of L. casei Shirota probiotic dairy drinks with global distribution; an established incumbent competing for the same end-consumer gut-health demand as Sanprobi.
• Procter & Gamble (Align): Owns the Align probiotic supplement franchise built on Bifidobacterium 35624, sold through drugstores and mass-market channels — broad incumbent in probiotic supplements.
• Sanofi Consumer Health (Enterogermina): Global pharma CPG brand selling Bacillus clausii probiotic supplements (Enterogermina) across multiple European and emerging markets — broad incumbent with overlapping probiotic supplement positioning.

Direct peers

• BioGaia: Swedish probiotic company developing and selling clinically documented Lactobacillus reuteri probiotic supplements for gut, immune, and oral health — directly comparable to Sanprobi in the strain-specific, science-led probiotic supplement category.
• Culturelle (i-Health / DSM-Firmenich): One of the largest branded probiotic supplement franchises built on a single L. rhamnosus GG strain, sold through pharmacies and retailers — directly comparable to Sanprobi in branded probiotic supplement go-to-market and pharmacy distribution.
• Lallemand Health Solutions: Canadian probiotic strain and formulation manufacturer supplying branded probiotic supplements globally — directly comparable to Sanprobi in probiotic strain development, in-house production, and finished-format distribution.
• Probi AB: Swedish probiotic ingredient and finished-product company with proprietary strains (e.g., L. plantarum 299v) and B2B/B2C channels — directly comparable to Sanprobi as a science-driven probiotic manufacturer selling through health/pharmacy channels.

Regional players

• Dr. Max Pharma Poland: One of the largest Polish pharmacy chains and a significant private-label supplement channel; relevant regional comp as Sanprobi's main distribution outlet and potential vertical partner or competitor.

Market position

Strengths5 records

Weaknesses5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Sanprobi1
• Facebookfacebook.com/sanprob
• LinkedInlinkedin.com/company/sanprobi

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanprobi